Kristi Holmes

@kristiholmes.bsky.social

Professor and Director at Northwestern University - Leveraging collaborative information initiatives to drive discovery and health #openscience

Through Advarra’s Council for Responsible Use of #AI in Clinical Trials, we worked with a diverse group from academia and industry to create a framework that introduces a practical, risk-based approach based on the degree of AI autonomy and patient impact. Access the document: hubs.la/Q04d5zKW0

Bild

Excited to share this new #CGR paper 🤩 It has been a real joy to work with the awesome NIH/NLM/NCBI team. HUGE kudos to paper lead E Tvedte & thanks also to coauthors! Thank you CGR working group, NIH exec steering committee, T Murphy, & V Schneider for championing the #CGR vision forward!

BF Francis Ouellette@bffo.bsky.social · 8mo ago

From @lrasmus.bsky.social, @kristiholmes.bsky.social et al. in @plos.org #Computational #Biology | Ten quick tips for using the NIH Comparative Genomics Resource | #Bioinformatics #Education #Genomics #PLOSCBQT #NCBI 🧬 🖥️ 🧪 🔓 CC/ @ppalagi.bsky.social ⬇️ journals.plos.org/ploscompbiol...

What defines research impact? New research shows that many of the most influential papers appear in lower-tier journals, highlighting why article-level metrics matter for recognizing individual contributions. Read more in @plosbiology.org: plos.io/4p5jRfH

PLOS Biology@plosbiology.org · 9mo ago

Are authors fairly judged by assessing the #journals in which their work is published? @bihutchins.bsky.social &co reveal that most influential papers are published in lower tier journals, and more authors would be better recognized with #ArticleLevelMetrics #ALMs @plosbiology.org 🧪 plos.io/4oV58Ed

Standing on the shoulders of giants. Researchers (nodes) at early (red), mid (blue) and late (grey) career stage who have built on one another's work (edges). Large nodes are researchers whose work would not be recognized with journal level metrics but would be recognized with article level metrics. Credit: B. Ian Hutchins

A review of health records from more than 130,000 adults found that people who used melatonin for a year or longer were significantly more likely to develop heart failure, be hospitalized for it, or die from any cause within five years.

Melatonin for sleep linked to 90% higher risk of heart failure, study finds

A major American Heart Association analysis suggests that long-term melatonin use for sleep could be linked to a higher risk of heart failure and death among adults with chronic insomnia.

bit.ly